Treatment and prevention of breast cancer

The drug is administered in the form of tamoxifin pill. This drug affects the activity of estrogen in the body. This is a drug that has been used for over 20 years, for the treatment of cancer patients with advanced breast cancer. In addition, cancer as an adjunct therapy after primary treatment of breast cancer at an early stage.

If the cancer is taken from women at high risk of breast cancer, tamoxifen reduces the riskto develop the disease. There are ongoing studies on cancer conducted for use in the prevention of breast cancer. In addition, there are studies, which are in the treatment of various other forms of cancer. It can also be used, the men in the treatment of breast cancer.

How does it work?

Some still have an anti-estrogen tamoxifen. The reason for this is because of how it works against the effect of estrogen on cells of the body. Estrogen is a naturaloccurring group of steroid compounds in the body that promotes the growth of some breast cancer cells. When used as a complementary treatment to surgery for cancer, aids in the prevention of breast cancer return. E 'was also shown to inhibit the development of new tumors in other breast.

What are the other benefits?

Even if it acts against the effects of estrogen in breast tissue, is behave like estrogen in other tissues. This means that those who can take the drug therapy derive many positive effects of estrogen replacement therapy in postmenopausal women. These are the lowest cholesterol, slow bone loss (osteoporosis).

E 'to prevent breast cancer?

Research has shown that if cancer is adjuvant therapy in early stage than in the chest, not only reduces the risk of recurrence of the original> Cancer, but also reduces the risk of developing breast cancer again others. It seems to help prevent breast cancer. These results as a basis, study, research, financed by a woman to determine the benefits of tamoxifen in preventing cancer breast. These are women who are at increased risk of developing the disease. This in-depth study), known as the Breast Cancer Prevention Trial (BCPT wasNational Surgical Adjuvant Breast conducted by and bowel Project (NSABP). It is a component of the NCI's Clinical Trials Cooperative Group Program. The study concluded that the reduction of 49 per cent in the diagnosis of invasive breast cancer in women who take tamoxifen have a. These same women also had 50 percent fewer diagnoses of noninvasive breast cancer such as lobular or ductal carcinoma in situ. Even with these good results are thereRisks associated with tamoxifen. Some of them are even life threatening. The decision to take or not take tamoxifen is still a person: check the woman and her doctor, like any other drug or treatment must carefully consider the benefits and risks of therapy.

The use of tamoxifen is not new. It 'been many more years, but still good option for the treatment of breast cancer. The combination of this treatment with a new reduction treatmentsthe number of deaths from breast cancer, and hopefully it will be more and more breast cancer do not.